Showing 1601-1610 of 10610 results for "".
The Future of Medical Research
https://reachmd.com/programs/conversations-on-health-care/the-future-of-medical-research/6877/This week, Mark and Margaret speak with Jack Andraka, 16 year old winner of last year's Intel Science and Engineering First Prize. Mr. Andraka has been nicamed the "Teen Prodigy of Pancreatic Cancer" by the Smithsonian for the device he created for early detection of pancreatic, ovarian and lung canThe Background on Background Checks for Future Health Care Employees
https://reachmd.com/programs/your-career-in-healthcare/the-background-on-background-checks-for-future-health-care-employees/6521/Why should employers run a background check on new hires? And why do small businesses in particular need to think about performing background checks? Robert Mather, CEO of Pre-Employ, of one of the largest background screening firms in the United States, running tens of thousands of background checkA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/a-case-of-missed-diagnosis-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37713/Examine a case of misdiagnosed proliferative diabetic retinopathy, highlighting risk factors, imaging findings, and referral timing.Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
https://reachmd.com/programs/neurofrontiers/advancements-in-gmg-management-zilucoplan-as-an-alternative-to-c5-inhibitors/32858/Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
https://reachmd.com/programs/cme/innovative-approaches-to-managing-ckm-syndrome-and-hfmrefhfpef/29912/CKM syndrome and HFmrEF/HFpEF present a rising global burden. Tune in to explore emerging therapies with a proven impact on outcomes.Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
https://reachmd.com/programs/cme/shifting-treatment-paradigm-in-hfmrefhfpef-steroidal-and-nonsteroidal-mras/29908/Listen in as Drs. McMurray and Zannad explore steroidal vs. nonsteroidal MRAs—RALES, TOPCAT, FINEARTS-HF—and what it means for HFmrEF/HFpEF care.Cases From the Real World: 91-Year-Old Patient With Wet AMD and a Submacular Hemorrhage
https://reachmd.com/programs/cme/Cases-From-the-Real-World-91-Year-Old-Patient-With-Wet-AMD-and-a-Submacular-Hemorrhage/33168/Hear how Drs. Danny Mammo and Ted Leng are using second-generation retinal agents to manage patients with PEDs from nAMD.Equipment Financing vs. a Traditional Loan: What’s Best for My Business?
https://reachmd.com/topics/energy-based-devices/equipment-financing-vs-a-traditional-loan-whats-best-for-my-business/35130/It’s beneficial to weigh all your options for financing a large expenseCases From the Real World: 61-Year-Old With Wet AMD With a High Treatment Burden
https://reachmd.com/programs/cme/Cases-From-the-Real-World-61-Year-Old-With-Wet-AMD-With-a-High-Treatment-Burden/33169/Join Drs. Ted Leng and Danny Mammo as they explore their real-world experience with second-generation retinal agents for nAMD.Immunotherapy: Changing Patient Outcomes in SCLC
https://reachmd.com/programs/cme/immunotherapy-changing-patient-outcomes-in-sclc/10710/This activity offers expert insight into the practice-changing evidence on immunotherapy for the management of extensive-stage small cell lung cancer.